Anzeige
Mehr »
Mittwoch, 02.07.2025 - Börsentäglich über 12.000 News
Nach dem Genius Act: Dieses börsennotierte XRP-Unternehmen greift im Token-Finanzmarkt an!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
349 Leser
Artikel bewerten:
(2)

CQ Medical's Iris AirShuttle Patient Transfer Platform Recognized at Women in Innovation Award Showcase

AVONDALE, Pa., March 5, 2025 /PRNewswire/ -- The Iris AirShuttle, a patient transfer platform developed by CQ Medical, is designed to streamline the transfer of patients from procedures to imaging. Recently, it was featured at the Women in Innovation Award Showcase, an event that celebrated Professor Iris Grunwald from the University of Dundee, UK, along with her team at the Image Guided Therapy Research Facility (IGTRF). The event honored their pioneering contributions to healthcare innovation, awarding them a Purple Plaque for outstanding innovations and solutions that improve healthcare globally. Professor Grunwald led the clinical evaluation of the Iris AirShuttle, assessing its ability to streamline patient transfers, reduce physical strain on healthcare providers, and improve overall hospital workflow efficiency. The evaluation confirmed the AirShuttle's potential to enhance safety and reduce the risk of injuries among NHS staff.

Professor Grunwald along with her team demonstrates the Iris AirShuttle Patient Transfer Platform featured at the Women in Innovation Award Showcase.

"We are extremely grateful to have evaluated the Iris AirShuttle," said Professor Grunwald. "It is a simple yet transformative solution that will make patient transfers easier, protect NHS staff, and ultimately improve hospital workflow efficiency. The overwhelmingly positive response from healthcare professionals and industry leaders further validates the importance of implementing this innovation in clinical practice."
- Read more at:Stroke expert celebrated for 'game-changing' ideas | University of Dundee, UK

The Iris AirShuttle is an integral part of CQ Medical's Symphony® Imaging, Treatment & Transfer Solutions, which conveniently integrates the AirShuttle patient platform with the AirDrive system. This combination enables smooth and efficient patient transfers between imaging modalities and procedural platforms without the need for repositioning. Designed for use in CT, MR (up to 3 Tesla), and angiography, the Symphony solution ensures safe patient movement across various surfaces, including sheet-covered pads and mattresses, while minimizing the number of clinical staff required.

To learn how the Iris AirShuttle can help workflow efficiency, safety, and patient care, visit CQMedical.com.

About CQ Medical
CQ Medical is the global leader in developing high-quality, innovative, patient-centric radiotherapy and cancer therapy solutions. With primary locations in Iowa and Pennsylvania and employees worldwide, the company has more than 80 years of combined experience bringing advanced hardware and consumables for patient immobilization and positioning, fiducial markers, couchtops, and patient care products to the market.

For further information, please contact:

Lisa Vandenberg, Senior Director of Product Management & Marketing, lisa.vandenberg@CQmedical.com

COPYRIGHT © 2025 CQ Medical. All rights reserved. CQ Medical is a trademark of Medtec LLC. Symphony is a registered trademark of Qfix Systems LLC. AirDrive, AirDrive Caddie, AirDrive Trolley, AirShuttle, and Iris AirShuttle are trademarks of Qfix Systems LLC.

This press release contains information about products that may or may not be available in particular countries. These products may not be licensed in accordance with Canadian law. Each country has specific laws and regulations governing the commercialization of medical devices and the communication of information regarding medical devices in printed and digital media. Products appearing in this press release or on our website may or may not have received approval, clearance, or marketing authorization by a governmental regulatory body in any particular country or may have received approval, clearance, or marketing authorization for different indications and restrictions in different countries or may be for investigational use only.

CQ2025D3 Rev. 0

Photo - https://mma.prnewswire.com/media/2633602/CQ_Medical_Iris.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/cq-medicals-iris-airshuttle-patient-transfer-platform-recognized-at-women-in-innovation-award-showcase-302392272.html

© 2025 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.